V

Veru
D

VERU

0.63620
USD
-0.01
(-0.98%)
مغلق
حجم التداول
21,838
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
93,129,450
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACOR
    -0.26810
    (-30.48%)
    0.61160 USD
    A
    AGEN
    -0.11500
    (-4.06%)
    2.71500 USD
    A
    ALRN
    0.12000
    (6.86%)
    1.87000 USD
    C
    CTMX
    0.00000
    (0.00%)
    1.09000 USD
    E
    ESPR
    0.05000
    (2.29%)
    2.23000 USD
    L
    LPCN
    0.05000
    (1.03%)
    4.91000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VKTX
    0.045
    (0.11%)
    42.315 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار
المقالات

العنوان: Veru

القطاع: Healthcare
الصناعة: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.